“Ozempic breath” is boosting Hershey’s sales of mints and gum

Candy giant Hershey is getting a sales boost from an unexpected consumer segment: users of GLP-1 weight-loss drugs. Hershey CEO Kirk Tanner said in the company’s first-quarter earnings call on Thursday that while appetite suppressants are leading customers to consume smaller portions of popular snacks, the drugs are also boosting demand for breath fresheners.  The company…

Read More